NeXtGen Biologics, INC — Form D
NeXtGen Biologics, INC of Alachua, FL, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-27. $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-27
- Form: D
- Accession: 0001415889-18-001836
- Industry: Biotechnology
- Exemptions: 06c
- Amount sold: $2.2M
- Investors: 19
- Date of first sale: 2018-12-13
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-328974
Issuer
- Name: NeXtGen Biologics, INC
- CIK: 0001620524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 13800 Tech City Circle, Alachua, FL, 32615
- Phone: 800-209-7190
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mark Gold | Director | West Chester, PA |
| Mark Hamister | Director | Alachua, FL |
| Elad Levy | Director | Alachua, FL |
| Rick Wassel | Director | Alachua, FL |
| Gerald Kluft | Director | Alachua, FL |
| Jonelle Toothman | Director | Alachua, FL |
| Jonelle Toothman | Executive Officer | Alachua, FL |
| Jamie Grooms | Director | Alachua, FL |
| Jamie Grooms | Executive Officer | Alachua, FL |
| Dan Hamister | Director | Alachua, FL |
| Brian Lipke | Director | Alachua, FL |
Other filings by this issuer (6)
More